Literature DB >> 6543654

Haemopoietic stem cells and the problem of self-renewal.

T M Dexter, E Spooncer, R Schofield, B I Lord, P Simmons.   

Abstract

Haemopoiesis occurs in association with a complex stromal cell network in which all levels of haemopoietic cell development can be found. In order to understand the interaction between stromal cells and growth factors with the processes of self-renewal and differentiation, we have carried out a series of experiments attempting to define the circumstances in which self-renewal occurs in long-term marrow cultures. We have found that highly purified (FACS sorted) CFU-S do not undergo significant self-renewal in vitro when inoculated onto marrow stromal cells that can support self-renewal of unfractionated CFU-S. We have examined the effects of expression of the src oncogene on self-renewal of CFU-S. We have found that, following infection of long-term cultures with a retrovirus carrying the src oncogene, there is expression of src in certain of the stromal cells. There is also a selection for CFU-S that have an extended self-renewal capacity in vivo and in vitro. These CFU-S are non-leukaemic and can reconstitute haempoiesis in irradiated mice. Cells from src-infected cultures can also be induced to proliferate and form cell lines in vitro in the presence of interleukin 3 (IL-3). The cell lines produced are multipotential and non-leukaemic. From such data we conclude that expression of the src oncogene has (directly or indirectly) permanently altered the stem cells in such a way that they can undergo extensive self-renewal in situations that are unfavourable for growth and self-renewal of normal stem cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6543654

Source DB:  PubMed          Journal:  Blood Cells        ISSN: 0340-4684


  14 in total

Review 1.  Stem cells in normal growth and disease.

Authors:  T M Dexter
Journal:  Br Med J (Clin Res Ed)       Date:  1987-11-07

Review 2.  The exciting prospects of new therapies with mesenchymal stromal cells.

Authors:  Darwin J Prockop
Journal:  Cytotherapy       Date:  2016-10-18       Impact factor: 5.414

3.  Pharmaceutical modulation of canonical Wnt signaling in multipotent stromal cells for improved osteoinductive therapy.

Authors:  Ulf Krause; Sean Harris; Angela Green; Joni Ylostalo; Suzanne Zeitouni; Narae Lee; Carl A Gregory
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-11       Impact factor: 11.205

4.  Negative impact of bone-marrow-derived mesenchymal stem cells on dextran sulfate sodium-induced colitis.

Authors:  Young-Sun Nam; Nayoun Kim; Keon-Il Im; Jung-Yeon Lim; Eun-Sol Lee; Seok-Goo Cho
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

5.  B lymphocytes express and lose syndecan at specific stages of differentiation.

Authors:  R D Sanderson; P Lalor; M Bernfield
Journal:  Cell Regul       Date:  1989-11

6.  Differentiation of erythroid progenitor (CFU-E) cells from mouse fetal liver cells and murine erythroleukemia (TSA8) cells without proliferation.

Authors:  T Noguchi; H Fukumoto; Y Mishina; M Obinata
Journal:  Mol Cell Biol       Date:  1988-06       Impact factor: 4.272

Review 7.  The role of growth factors in haemopoietic development: clinical and biological implications.

Authors:  C P Daniel; T M Dexter
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

Review 8.  The potential use of mesenchymal stem cells in hematopoietic stem cell transplantation.

Authors:  Eun-Jung Kim; Nayoun Kim; Seok-Goo Cho
Journal:  Exp Mol Med       Date:  2013-01-10       Impact factor: 8.718

9.  Highly restricted expression of a stromal cell determinant in mouse bone marrow in vivo.

Authors:  K Jacobsen; K Miyake; P W Kincade; D G Osmond
Journal:  J Exp Med       Date:  1992-10-01       Impact factor: 14.307

10.  Tenascin is a cytoadhesive extracellular matrix component of the human hematopoietic microenvironment.

Authors:  G Klein; S Beck; C A Müller
Journal:  J Cell Biol       Date:  1993-11       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.